- Home
- LITB vs CRIS Comparison
LITB vs CRIS Comparison
Compare LITB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- CRIS
- Stock Information
- Founded
- LITB 2007
- CRIS 2000
- Country
- LITB Singapore
- CRIS United States
- Employees
- LITB N/A
- CRIS N/A
- Industry
- LITB Catalog/Specialty Distribution
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- CRIS Health Care
- Exchange
- LITB Nasdaq
- CRIS Nasdaq
- Market Cap
- LITB N/A
- CRIS 32.8M
- IPO Year
- LITB N/A
- CRIS 2000
- Fundamental
- Price
- LITB $1.00
- CRIS $2.84
- Analyst Decision
- LITB
- CRIS Strong Buy
- Analyst Count
- LITB 0
- CRIS 3
- Target Price
- LITB N/A
- CRIS $23.00
- AVG Volume (30 Days)
- LITB 21.6K
- CRIS 28.2K
- Earning Date
- LITB 03-24-2025
- CRIS 05-06-2025
- Dividend Yield
- LITB N/A
- CRIS N/A
- EPS Growth
- LITB N/A
- CRIS N/A
- EPS
- LITB N/A
- CRIS N/A
- Revenue
- LITB $333,093,000.00
- CRIS $10,259,000.00
- Revenue This Year
- LITB N/A
- CRIS N/A
- Revenue Next Year
- LITB N/A
- CRIS N/A
- P/E Ratio
- LITB N/A
- CRIS N/A
- Revenue Growth
- LITB N/A
- CRIS 0.44
- 52 Week Low
- LITB $0.91
- CRIS $2.57
- 52 Week High
- LITB $6.00
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- LITB 41.05
- CRIS 41.65
- Support Level
- LITB $0.92
- CRIS $2.57
- Resistance Level
- LITB $1.05
- CRIS $3.15
- Average True Range (ATR)
- LITB 0.05
- CRIS 0.17
- MACD
- LITB 0.01
- CRIS -0.02
- Stochastic Oscillator
- LITB 61.54
- CRIS 44.26
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.